Purpose: The aim of this study was to retrospectively analyze outcomes of flexible ureteroscopy and laser fragmentation (FURSL) of renal stones with the use of ureteral access sheath (UAS) in the pediatric population.
Materials And Methods: We retrospectively collected data between January 2011 and January 2018 for patient demographics, stone characteristics, and outcomes in 21 children who underwent FURSL with the use of UAS.
Results: Twenty-one patients (10 boys and 11 girls) with a mean age of 11.
Aims: The use of ureteroscopy in treating paediatric stone disease has risen in recent years. We retrospectively reviewed the results of ureteroscopic stone management for our regional paediatric stone service.
Material And Methods: Between April 2010 and October 2013, consecutive patients undergoing ureteroscopy and stone fragmentation were identified.
World J Gastrointest Endosc
June 2014
The use of simulation based training in endoscopy has been increasingly described, simulation has the potential reduce the harm caused to patients by novices performing procedures, increase efficiency by reducing the time needed to train in the clinical environment and increase the opportunity to repeatedly practice rare procedures as well as allowing the assessment of performance. Simulators can consist of mechanical devices, employ cadaveric animal tissue or use virtual reality technology. Simulators have been used to teach upper and lower gastrointestinal endoscopy as well as interventional procedures.
View Article and Find Full Text PDFThe development of a screening test for cervical dysplasia has been a major force in diminishing the worldwide incidence of invasive cervical cancer. Screening intervals recommended by professional organizations have changed over the past half century. Recognition of the human papillomavirus (HPV) as the causative agent and enhanced understanding of the natural history of HPV and cervical dysplasia in different age groups have prompted the American College of Obstetricians and Gynecologists and other professional societies to defer Pap smear screening to intervals no less than 2 years apart in women 21-29, and every 3 years in women 30 and over assuming no prior history of cervical dysplasia.
View Article and Find Full Text PDFCarboplatin is an alkylating agent that is FDA approved for the treatment of advanced ovarian cancer. Paclitaxel is a plant taxane mitotic inhibitor approved for primary or salvage treatment of ovarian and breast cancer. This is a case report of a 40-year-old woman who was exclusively breastfeeding prior to being treated for papillary thyroid cancer with intravenous carboplatin (233 mg) and intravenous paclitaxel (30 mg/m(2)) for 6 consecutive weeks.
View Article and Find Full Text PDFPurpose: This retrospective study was designed to assess the impact of shock wave lithotripsy on the pediatric kidney using pretreatment and posttreatment (99m)technetium dimercapto-succinic acid renal scintigram.
Materials And Methods: A total of 182 patients 5 months to 19.8 years old (mean 5.